诺和诺德称减肥药Wegovy 口服片剂已在美国获批

Core Insights - Novo Nordisk announced that Wegovy oral tablets have been approved in the United States, marking the first oral GLP-1 medication for weight management [1] - The company plans to launch Wegovy oral tablets in the U.S. in January 2026 [1] - The weight loss effect of Wegovy oral tablets is comparable to that of the Wegovy 2.4mg injection [1] - In the OASIS4 trial, one in three participants experienced a weight loss of 20% or more [1]